Adolescents with Human Immunodeficiency Virus (HIV) in Botswana, South Africa, Thailand, Uganda and the United States who ...
A Northwestern Medicine study published in Nature Communications has revealed how HIV can protect infected cells by altering the sugars on their surface, hindering the host immune system and avoiding ...
Thousands in Florida who rely on the AIDS Drug Assistance Program will see their coverage cut or their medication changed, ...
Using participant skin cells reprogrammed into neurons, Weill Cornell Medicine researchers have identified genetic signatures ...
Gilead study finds HIV can evolve to resist lenacapavir, but doing so hampers the virus' replication
Now, Gilead has conducted an analysis of a phenomenon that can undermine all infectious disease therapies, including ...
The immune system remains seriously out-of-whack—in an inflammatory state of overactivation and impaired ...
In patients with HIV infection on rifampicin TB therapy, twice-daily bictegravir/emtricitabine/tenofovir alafenamide results ...
The CDC estimates 2.2 million Americans could benefit from HIV prevention drugs, but just over a quarter of that group have ...
At least 1.4 million Kenyans are living with HIV, with approximately 21,009 people estimated to have died from AIDS-related ...
Kenya's Ministry of Health said on Saturday that it has approved the rollout of lenacapavir, a twice-yearly HIV prevention Kenya breaking news | Kenya news today | ...
Gilead Sciences' new HIV prevention drug has been added to CVS Health's commercial insurance plans, the drugmaker's CEO ...
There is a need to address wrong theological teachings that prescribe only to miracle cure of HIV/Aids and denigrate science ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback